Biogen Inc. (BIIB)
NASDAQ: BIIB · IEX Real-Time Price · USD
200.45
-2.01 (-0.99%)
Apr 26, 2024, 9:30 AM EDT - Market open
Biogen Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 - 1995 |
---|---|---|---|---|---|---|---|---|---|---|---|
Cash & Equivalents | 1,050 | 3,419 | 2,261 | 1,331 | 2,914 | 1,225 | 1,574 | 2,327 | 1,308 | 1,205 | Upgrade
|
Short-Term Investments | 0 | 1,474 | 1,541 | 1,279 | 1,562 | 2,313 | 2,115 | 2,569 | 2,121 | 640.5 | Upgrade
|
Cash & Cash Equivalents | 1,050 | 4,893 | 3,803 | 2,610 | 4,476 | 3,538 | 3,689 | 4,895 | 3,429 | 1,845 | Upgrade
|
Cash Growth | -78.54% | 28.67% | 45.68% | -41.69% | 26.51% | -4.09% | -24.64% | 42.78% | 85.79% | 50.92% | Upgrade
|
Receivables | 2,100 | 2,136 | 1,962 | 2,327 | 2,471 | 2,485 | 2,320 | 1,742 | 1,542 | 1,576 | Upgrade
|
Inventory | 2,527 | 1,344 | 1,352 | 1,069 | 804.2 | 929.9 | 902.7 | 1,002 | 893.4 | 804 | Upgrade
|
Other Current Assets | 1,182 | 1,418 | 740.8 | 881.1 | 631 | 687.6 | 962 | 1,093 | 836.9 | 309.8 | Upgrade
|
Total Current Assets | 6,859 | 9,791 | 7,857 | 6,887 | 8,382 | 7,641 | 7,873 | 8,732 | 6,700 | 4,535 | Upgrade
|
Property, Plant & Equipment | 3,730 | 3,703 | 3,792 | 3,845 | 3,674 | 3,601 | 3,182 | 2,502 | 2,188 | 1,766 | Upgrade
|
Long-Term Investments | 745 | 2,235 | 2,832 | 3,671 | 2,661 | 3,067 | 3,489 | 4,165 | 3,868 | 2,225 | Upgrade
|
Goodwill and Intangibles | 14,582 | 7,599 | 7,982 | 8,846 | 9,285 | 8,826 | 8,512 | 7,478 | 6,749 | 5,789 | Upgrade
|
Other Long-Term Assets | 928.6 | 1,226 | 1,415 | 1,370 | 3,232 | 2,154 | 595.9 | 0 | 0 | 0 | Upgrade
|
Total Long-Term Assets | 19,986 | 14,763 | 16,021 | 17,732 | 18,853 | 17,648 | 15,779 | 14,145 | 12,805 | 9,780 | Upgrade
|
Total Assets | 26,845 | 24,554 | 23,877 | 24,619 | 27,234 | 25,289 | 23,653 | 22,877 | 19,505 | 14,315 | Upgrade
|
Accounts Payable | 403.3 | 491.5 | 589.2 | 454.9 | 530.8 | 370.5 | 395.5 | 279.8 | 267.4 | 229.2 | Upgrade
|
Current Debt | 150 | 0 | 999.1 | 0 | 1,496 | 0 | 3.2 | 4.7 | 4.8 | 3.1 | Upgrade
|
Other Current Liabilities | 2,881 | 2,781 | 2,710 | 3,287 | 2,837 | 2,925 | 2,970 | 3,135 | 2,306 | 1,986 | Upgrade
|
Total Current Liabilities | 3,434 | 3,273 | 4,298 | 3,742 | 4,864 | 3,295 | 3,368 | 3,420 | 2,578 | 2,218 | Upgrade
|
Long-Term Debt | 7,188 | 6,614 | 6,604 | 7,828 | 4,872 | 5,937 | 5,935 | 6,513 | 6,522 | 580.3 | Upgrade
|
Other Long-Term Liabilities | 1,423 | 1,279 | 2,015 | 2,362 | 4,160 | 3,026 | 1,751 | 815.6 | 1,031 | 702.3 | Upgrade
|
Total Long-Term Liabilities | 8,611 | 7,893 | 8,619 | 10,191 | 9,031 | 8,962 | 7,686 | 7,328 | 7,552 | 1,283 | Upgrade
|
Total Liabilities | 12,045 | 11,166 | 12,918 | 13,933 | 13,895 | 12,257 | 11,055 | 10,748 | 10,130 | 3,501 | Upgrade
|
Total Debt | 7,338 | 6,614 | 7,604 | 7,828 | 6,368 | 5,937 | 5,938 | 6,517 | 6,526 | 583.4 | Upgrade
|
Debt Growth | 10.95% | -13.01% | -2.87% | 22.94% | 7.26% | -0.03% | -8.89% | -0.14% | 1018.67% | -2.10% | Upgrade
|
Retained Earnings | 17,628 | 16,467 | 13,912 | 13,976 | 16,455 | 16,257 | 15,810 | 15,072 | 12,208 | 9,284 | Upgrade
|
Comprehensive Income | -153.7 | -164.9 | -106.7 | -299 | -135.2 | -240.4 | -318.4 | -319.9 | -224 | -59.5 | Upgrade
|
Shareholders' Equity | 14,799 | 13,398 | 10,896 | 10,700 | 13,343 | 13,040 | 12,613 | 12,140 | 9,373 | 10,809 | Upgrade
|
Net Cash / Debt | -6,288.3 | -1,721.2 | -3,801 | -5,218.1 | -1,891.6 | -2,398.5 | -2,249.2 | -1,622.3 | -3,097.8 | 1,262 | Upgrade
|
Net Cash / Debt Growth | - | - | - | - | - | - | - | - | - | 101.34% | Upgrade
|
Net Cash Per Share | -43.19 | -11.79 | -25.41 | -32.35 | -10.09 | -11.68 | -10.56 | -7.41 | -13.40 | 5.32 | Upgrade
|
Working Capital | 3,425 | 6,518 | 3,558 | 3,145 | 3,518 | 4,346 | 4,505 | 5,312 | 4,123 | 2,317 | Upgrade
|
Book Value Per Share | 102.28 | 92.21 | 73.08 | 66.50 | 71.32 | 63.64 | 59.33 | 55.59 | 40.63 | 45.72 | Upgrade
|